Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors.
Xu, Y.Z., Yuan, S., Bowers, S., Hom, R.K., Chan, W., Sham, H.L., Zhu, Y.L., Beroza, P., Pan, H., Brecht, E., Yao, N., Lougheed, J., Yan, J., Tam, D., Ren, Z., Ruslim, L., Bova, M.P., Artis, D.R.(2013) Bioorg Med Chem Lett 23: 3075-3080
- PubMed: 23570791 
- DOI: https://doi.org/10.1016/j.bmcl.2013.03.009
- Primary Citation of Related Structures:  
4I0D, 4I0E, 4I0F, 4I12, 4I1C - PubMed Abstract: 
Utilizing a structure based design approach, combined with extensive medicinal chemistry execution, highly selective, potent and novel BACE1 inhibitor 8 (BACE1 Alpha assay IC50=8nM) was made from a weak μM potency hit in an extremely efficient way. The detailed SAR and general design approaches will be discussed.
Organizational Affiliation: 
Department of Chemical Sciences, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, CA 94080, USA. ying_zi_xu@yahoo.com